Tradestie Institutional Equity Comparison Engine

RKTO vs PALI โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

PALI Overall Edge

PALI Captures Institutional Edge (3โ€“0 Pillars ยท 6โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Palisade Bio, Inc. Common Stock (PALI) driven by superior Valuation, Growth & Margin, Momentum & Technical. Fundamentally, RKTO trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus PALI at N/M Forward P/E and -9625.4% operating margin (+0.0% YoY). In options structure, RKTO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against PALI sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner PALI
RKTO N/M vs PALI N/M Fwd P/E
Growth & Margin Winner PALI
Op Margin N/A vs -9625.4% ยท YoY N/A vs +0.0%
Momentum & Technical Winner PALI
1Y -82.5% vs -61.3% ยท 52W Pos 2% vs 0%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
RKTO US Equity
RKTO
Institutional Equity
$0.30
+6.11% 1D
Market Cap N/A
1M Return -44.23%
1Y Return -82.53%
Forward P/E N/M
Unified AI Score
44.2 / 100 HOLD
Tech 45.0 Fund 42.0 Flow 50.0 Mom 55.0
PALI NASDAQ
Palisade Bio, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$0.84
-9.24% 1D
Market Cap $166.1M
1M Return -37.79%
1Y Return -61.29%
Forward P/E N/M
Unified AI Score
39.3 / 100 SELL
Tech 25.0 Fund 43.0 Flow 50.0 Mom 55.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: RKTO -82.53% PALI -61.29% Spread: +23.3 pp (PALI Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
RKTO TTM Op. Margin: N/A PALI TTM Op. Margin: -9625.4%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on RKTO vs PALI. Trailing 12-month operating profitability (RKTO N/A vs PALI -9625.4%) and valuation multiples (RKTO N/M vs PALI N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: RKTO (3) vs PALI (6)
Institutional Metric RKTO PALI Criterion Row Winner
Market Capitalization Scale N/A $166.1M Larger Scale PALI
Trailing P/E Ratio Valuation N/M 1.0x Lower Multiple PALI
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A +0.0% Higher Growth PALI
Operating Margin (TTM) Profitability N/A -9625.4% Higher Margin PALI
Net Profit Margin Profitability N/A 0.0% Higher Margin PALI
Return on Equity (ROE) Capital Efficiency N/A -75.6% Higher ROE PALI
52-Week Range Position Momentum 2% ($0โ€“$2) 0% ($1โ€“$3) Stronger Trend RKTO
Beta / 30D Volatility Risk Regime 1.16ฮฒ ยท 63% Vol 1.44ฮฒ ยท 70% Vol Lower Realized Risk RKTO
Unified Institutional Score Composite Signal 44.2 / 100 (HOLD) 39.3 / 100 (SELL) Higher Composite RKTO

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full RKTO vs PALI Buy Guide
RKTO UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live RKTO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
PALI UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live PALI Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither RKTO nor PALI registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.